BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36399270)

  • 1. Computational Approaches to Assess Abnormal Metabolism in Alzheimer's Disease Using Transcriptomics.
    Lüleci HB; Uzuner D; Çakır T; Thambisetty M
    Methods Mol Biol; 2023; 2561():173-189. PubMed ID: 36399270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-scale metabolic network reconstruction of model animals as a platform for translational research.
    Wang H; Robinson JL; Kocabas P; Gustafsson J; Anton M; Cholley PE; Huang S; Gobom J; Svensson T; Uhlen M; Zetterberg H; Nielsen J
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34282017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for Alzheimer's disease.
    Stempler S; Yizhak K; Ruppin E
    PLoS One; 2014; 9(8):e105383. PubMed ID: 25127241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking Human Brain Metabolism by Genome-Scale and Multiomics Metabolic Models: Relevance for Neurology Research, Health, and Disease.
    Sertbas M; Ulgen KO
    OMICS; 2018 Jul; 22(7):455-467. PubMed ID: 30004841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics.
    Verheijen J; Sleegers K
    Trends Genet; 2018 Jun; 34(6):434-447. PubMed ID: 29573818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease.
    Baloni P; Funk CC; Yan J; Yurkovich JT; Kueider-Paisley A; Nho K; Heinken A; Jia W; Mahmoudiandehkordi S; Louie G; Saykin AJ; Arnold M; Kastenmüller G; Griffiths WJ; Thiele I; ; Kaddurah-Daouk R; Price ND
    Cell Rep Med; 2020 Nov; 1(8):100138. PubMed ID: 33294859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teasing out missing reactions in genome-scale metabolic networks through hypergraph learning.
    Chen C; Liao C; Liu YY
    Nat Commun; 2023 Apr; 14(1):2375. PubMed ID: 37185345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of transcriptomic data in a genome-scale metabolic model to investigate the link between obesity and breast cancer.
    Granata I; Troiano E; Sangiovanni M; Guarracino MR
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):162. PubMed ID: 30999849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iMAT: an integrative metabolic analysis tool.
    Zur H; Ruppin E; Shlomi T
    Bioinformatics; 2010 Dec; 26(24):3140-2. PubMed ID: 21081510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease.
    Ryan M; Tan VTY; Thompson N; Guévremont D; Mockett BG; Tate WP; Abraham WC; Hughes SM; Williams J
    J Alzheimers Dis; 2021; 79(3):1075-1090. PubMed ID: 33386801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer's disease.
    Chen J; Xie C; Zhao Y; Li Z; Xu P; Yao L
    Oncotarget; 2016 Nov; 7(45):72469-72474. PubMed ID: 27732949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic function-based normalization improves transcriptome data-driven reduction of genome-scale metabolic models.
    Jalili M; Scharm M; Wolkenhauer O; Salehzadeh-Yazdi A
    NPJ Syst Biol Appl; 2023 May; 9(1):15. PubMed ID: 37210409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics-based promising candidate biomarkers and pathways in Alzheimer's disease.
    Kang J; Lu J; Zhang X
    Pharmazie; 2015 May; 70(5):277-82. PubMed ID: 26062293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Protocol for the Construction and Curation of Genome-Scale Integrated Metabolic and Regulatory Network Models.
    Chandrasekaran S
    Methods Mol Biol; 2019; 1927():203-214. PubMed ID: 30788794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometric gene-to-reaction associations enhance model-driven analysis performance: Metabolic response to chronic exposure to Aldrin in prostate cancer.
    Marín de Mas I; Torrents L; Bedia C; Nielsen LK; Cascante M; Tauler R
    BMC Genomics; 2019 Aug; 20(1):652. PubMed ID: 31416420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
    Elkahloun AG; Hafko R; Saavedra JM
    Alzheimers Res Ther; 2016 Jan; 8():5. PubMed ID: 26822027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human metabolism by reducing the complexity of the genome-scale models using redHUMAN.
    Masid M; Ataman M; Hatzimanikatis V
    Nat Commun; 2020 Jun; 11(1):2821. PubMed ID: 32499584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of metabolic states using genome-scale metabolic models.
    Sarathy C; Breuer M; Kutmon M; Adriaens ME; Evelo CT; Arts ICW
    PLoS Comput Biol; 2021 Nov; 17(11):e1009522. PubMed ID: 34748535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-scale metabolic models in translational medicine: the current status and potential of machine learning in improving the effectiveness of the models.
    Turanli B; Gulfidan G; Aydogan OO; Kula C; Selvaraj G; Arga KY
    Mol Omics; 2024 May; 20(4):234-247. PubMed ID: 38444371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.